ArticleAntimicrobial agents and chemotherapy2004

In vitro activities of a novel cephalosporin, CB-181963 (CAB-175), against methicillin-susceptible or -resistant Staphylococcus aureus and glycopeptide-intermediate susceptible staphylococci.

Vanthida Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.